http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2682596-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efe2ead8434bab6f47cfe08ee3db1f30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ad0c2f0e638bc64296d4094c721a343
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
filingDate 2007-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b13fef26f99871a5d518613dc360a372
publicationDate 2008-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2682596-A1
titleOfInvention Use of carboxyamidotriazole (cai) orotate in macular degeneration
abstract Method and composition of Carboxyamidotriazole orotate for treating age-related macular degeneration and other angiogenesis-dependent diseases.
priorityDate 2006-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419706697
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100334180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108144
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584632
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1492348
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81642
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8626236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12295187
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID820497

Total number of triples: 47.